» Articles » PMID: 25659159

DMSO Efficiently Down Regulates Pluripotency Genes in Human Embryonic Stem Cells During Definitive Endoderm Derivation and Increases the Proficiency of Hepatic Differentiation

Overview
Journal PLoS One
Date 2015 Feb 7
PMID 25659159
Citations 24
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Definitive endoderm (DE) is one of the three germ layers which during in vivo vertebrate development gives rise to a variety of organs including liver, lungs, thyroid and pancreas; consequently efficient in vitro initiation of stem cell differentiation to DE cells is a prerequisite for successful cellular specification to subsequent DE-derived cell types [1, 2]. In this study we present a novel approach to rapidly and efficiently down regulate pluripotency genes during initiation of differentiation to DE cells by addition of dimethyl sulfoxide (DMSO) to Activin A-based culture medium and report its effects on the downstream differentiation to hepatocyte-like cells.

Materials And Methods: Human embryonic stem cells (hESC) were differentiated to DE using standard methods in medium supplemented with 100ng/ml of Activin A and compared to cultures where DE specification was additionally enhanced with different concentrations of DMSO. DE cells were subsequently primed to generate hepatic-like cells to investigate whether the addition of DMSO during formation of DE improved subsequent expression of hepatic markers. A combination of flow cytometry, real-time quantitative reverse PCR and immunofluorescence was applied throughout the differentiation process to monitor expression of pluripotency (POUF5/OCT4 & NANOG), definitive endoderm (SOX17, CXCR4 & GATA4) and hepatic (AFP & ALB) genes to generate differentiation stage-specific signatures.

Results: Addition of DMSO to the Activin A-based medium during DE specification resulted in rapid down regulation of the pluripotency genes OCT4 and NANOG, accompanied by an increase expression of the DE genes SOX17, CXCR4 and GATA4. Importantly, the expression level of ALB in DMSO-treated cells was also higher than in cells which were differentiated to the DE stage via standard Activin A treatment.

Citing Articles

Time-efficient strategies in human iPS cell-derived pancreatic progenitor differentiation and cryopreservation: advancing towards practical applications.

Genova E, Rispoli P, Fengming Y, Kohei J, Bramuzzo M, Bulla R Stem Cell Res Ther. 2024; 15(1):483.

PMID: 39695795 PMC: 11658428. DOI: 10.1186/s13287-024-04068-6.


Small Molecule-Mediated Stage-Specific Reprogramming of MSCs to Hepatocyte-Like Cells and Hepatic Tissue for Liver Injury Treatment.

Gupta S, Sharma A, Rajakannu M, Bisevac J, Rela M, Verma R Stem Cell Rev Rep. 2024; 20(8):2215-2235.

PMID: 39259445 PMC: 11554881. DOI: 10.1007/s12015-024-10771-x.


Pluripotent Stem Cell-Derived Hepatocyte-like Cells: Induction Methods and Applications.

Luo Q, Wang N, Que H, Mai E, Hu Y, Tan R Int J Mol Sci. 2023; 24(14).

PMID: 37511351 PMC: 10380504. DOI: 10.3390/ijms241411592.


Transcriptional and Epigenetic Consequences of DMSO Treatment on HepaRG Cells.

Dubois-Pot-Schneider H, Aninat C, Kattler K, Fekir K, Jarnouen K, Cerec V Cells. 2022; 11(15).

PMID: 35892596 PMC: 9331440. DOI: 10.3390/cells11152298.


Efficiently generate functional hepatic cells from human pluripotent stem cells by complete small-molecule strategy.

Pan T, Wang N, Zhang J, Yang F, Chen Y, Zhuang Y Stem Cell Res Ther. 2022; 13(1):159.

PMID: 35410439 PMC: 8996222. DOI: 10.1186/s13287-022-02831-1.


References
1.
Lemaigre F . Mechanisms of liver development: concepts for understanding liver disorders and design of novel therapies. Gastroenterology. 2009; 137(1):62-79. DOI: 10.1053/j.gastro.2009.03.035. View

2.
Fletcher J, Cui W, Samuel K, Black J, Hannoun Z, Currie I . The inhibitory role of stromal cell mesenchyme on human embryonic stem cell hepatocyte differentiation is overcome by Wnt3a treatment. Cloning Stem Cells. 2008; 10(3):331-9. DOI: 10.1089/clo.2007.0094. View

3.
Ochiya T, Yamamoto Y, Banas A . Commitment of stem cells into functional hepatocytes. Differentiation. 2009; 79(2):65-73. DOI: 10.1016/j.diff.2009.10.002. View

4.
Touboul T, Hannan N, Corbineau S, Martinez A, Martinet C, Branchereau S . Generation of functional hepatocytes from human embryonic stem cells under chemically defined conditions that recapitulate liver development. Hepatology. 2010; 51(5):1754-65. DOI: 10.1002/hep.23506. View

5.
Rowntree R, McNeish J . Induced pluripotent stem cells: opportunities as research and development tools in 21st century drug discovery. Regen Med. 2010; 5(4):557-68. DOI: 10.2217/rme.10.36. View